Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

Several weeks after reporting positive results for nerandomilast for idiopathic pulmonary fibrosis, Boehringer Ingelheim ...

Adults with progressive pulmonary fibrosis met the primary endpoint of absolute change in FVC with 52-week oral nerandomilast ...

The new data from the 1,178-patient FIBRONEER-ILD study showed that the oral PDE 4B inhibitor was able to improve lung function in patients with progressive pulmonary fibrosis (PPF), a form of ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...

The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...

The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...